OTTAWA Transport Canada has released updated guidelines for testing automated driving systems (ADS), which will apply to any organization conducting R&D trials of vehicles equipped with ADS. The guidelines are meant to clarify the roles and responsibilities of federal, provincial/territorial and municipal governments as they relate to trial organizations and to establish a baseline of…
Organization: Entos Pharmaceuticals
The Short Report – Dec. 8, 2021: Ontario launches flagship EV program, Alberta boosts vaccine development capacity, applied research on the rise, and more
The launch of Ontario’s vehicle innovation network signals readiness for next-generation auto solutions, Alberta invests tens of millions of dollars to fund vaccine research and manufacturing capacity, research activity continues to grow at colleges and institutes across Canada, and more.
The Short Report – March 3, 2021: A report on inclusive innovation, an urban health research network, a potential DARPA for Canada, and more
The Brookfield Institute and the Munk School of Global Affairs produce an online tool to monitor data and analysis of Canada’s inclusive innovation system; U of T and Denmark’s Novo Nordisk A/S invest $40 million on supporting healthier urban populations and finding solutions for chronic illnesses, and more.
Calgary vaccine developer reaches deal with Manitoba government after hearing no response from Ottawa
Providence Therapeutics, a Calgary biotechnology company in human trials with its COVID-19 vaccine, struck a supply deal with the Government of Manitoba after sending the federal government a proposal and receiving no response. In a video, Providence founder and CEO Brad Sorenson criticized Ottawa’s “apathetic response” as “unacceptable” and he implored the government to take initiative to establish a secure domestic vaccine supply.
The Short Report – Nov. 4th, 2020: Tracking international travellers for COVID-19; $26 million for doctoral researchers, and more…
Surveillance border study at Toronto’s airport continues to track international travellers for COVID-19; the Canadian Space Agency supports the launch of two lunar technology payloads to the moon.
Feds invest $887 million to ensure reliable vaccine supply for COVID-19, other pandemics
The federal government’s investment of $887 million make Canada self-sufficient in manufacturing vaccines against COVID-19 and future pandemics, say medical and other experts. Along with Canadian-led vaccine development, Ottawa is investing in a network of small-scale vaccine manufacturing facilities that together will be able to produce enough vaccine for Canada’s population during pandemics.
Applied PeR$pectives
Building with CCNB-INNOV… Relationships that go a Long Way! CCNB-INNOV, the applied research and development arm of CCNB has adapted its range of services to better meet the unique needs of the regional shipbuilding industry.
 |
Applied PeR$pectives is a new monthly blog dedicated to highlighting the innovative work being done in the college and institute community. |
|---|
Fast Policy Facts
 |
December 12, 2018: Requiem for a National Network Program
|
|---|
Research Money on Twitter
Loading tweets...